• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MO SCI Acquires Assets of 3M’s Advanced Materials Business

    Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets

    Aspivix's Carevix Cervical Stabilizer Gains FDA OK

    Apyx Medical Submits 510(k) App for Renuvion APR Handpiece

    LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Deducing the Dual Reality of Elizabeth Holmes

    The Return of the AdvaMed MedTech Conference…Live!

    Material Matters: New Materials Call for New Thinking

    5 Ways to Maintain a Talent-Centric Mindset, Even During Economic Uncertainty

    The Changing Face of UK Medical Device Regulations: Most Recent Update
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    Providence Enterprise USA Inc.

    Paragon Medical

    Halkey-Roberts Corporation

    LEMO USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Onshoring Medical Device Manufacturing Can Strengthen Supply Chains

    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    Providence Enterprise USA Inc.

    Paragon Medical

    Halkey-Roberts Corporation

    LEMO USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Private Equity’s Impact on Medical Product Outsourcing

    ...

    Private Equity’s Impact on Medical Product Outsourcing
    Related Content
    • Millstone Medical Outsourcing
    • Medical Device Funding: Any Signs of Life?
    • Sounding Board: The BD-Bard Transaction
    • Winners Announced for Qualcomm Tricorder XPRIZE
    • The Tax that Wouldn’t Die
    Ben Dunn, Covington Associates06.09.16
    The landscape of medical product outsourcing (MPO) providers has changed dramatically over the past decade. New companies have formed, offering a broad range of solutions globally, while others have disappeared, resulting in a constantly evolving group of suppliers. While several factors have contributed to this evolution—OEM consolidation, globalization, market growth, etc.—a major element has been the emergence of private equity (PE) in this market.

    Simply mention the phrase “private equity” to a group of people and it will elicit a range of strong responses ranging from the highly positive to the highly negative, as people conjure images of either Warren Buffett or Gordon Gecko. Regardless of where one’s thoughts fall on this spectrum, there is no denying that private equity has made a significant impact. However, before delving into what impact private equity has had on the medical product outsourcing industry, we first need to look into why it has played a role at all.

    Private equity is not a new phenomenon and has been around for several decades. PE firms raise money from institutional investors such as pension funds and college endowments.
    The firms then pool these investments into specific funds, which are mandated to invest and return the capital within a given time frame (generally around 10 years). PE firms measure their performance by the internal rate of return (IRR) on their investments. To achieve the highest IRR, a firm needs to create the highest amount of value over the shortest period of time. While PE has existed for a long time, what has recently changed is the rapid growth of the medical product outsourcing industry.  Nowhere is this more evident than by looking at the amount of capital that has been raised—nearly $5 trillion globally over the past decade. Of this total amount, according to Pitchbook, U.S.-based PE firms hold a staggering $675 billion of uninvested capital that is waiting to be deployed into the acquisition of companies. This enormous amount of capital is (figuratively speaking) burning a hole in funds’ pockets, for if the funds do not use this money, they must return it to investors and the IRR will suffer. As a consequence, a record number of firms with large amounts of undeployed capital are scouring the globe in search of investment opportunities.

    With all of these firms and all of this capital, it is not surprising that they have been targeting medical manufacturing. Just about every single owner of a medical manufacturing business has received multiple calls, emails, or faxes from someone expressing interest in acquiring or investing in their business. Chances are the groups behind these unsolicited overtures are private equity firms. These groups are targeting medical product outsourcing not just because they have money to deploy, but because this market has a number of attributes that make it particularly attractive to private equity. Those attributes include:
    • A highly attractive market—The market for medical product outsourcing services, according to our estimates, is more than $30 billion and growing at over 10 percent annually—faster than the growth in the overall medical device industry. This large, growing market provides a range of opportunities to grow a business.
    • Exposure to the healthcare market—The healthcare market has much greater stability than the consumer or technology markets. The long term fundamentals of this market remain strong. MPO companies provide an easier and less risky entry into the healthcare market as opposed to making an investment into a medical device or medical provider-based company.
    • Market fragmentation—The highly fragmented nature of the MPO market provides ample opportunity for consolidation and the opportunity to achieve the benefits of economies of scale—two key plays in the private equity playbook.
    • Previous successful PE exits—A number of successful exits by PE-backed firms (MedSource International, UTI Corporation, Avail Medical Products Inc., Creganna Medical, AdvancedCath, Phillips-Medisize, and others) serve as validation to PE firms that this is a successful market for investors.
    The result of this interest has been a flurry of PE activity in the MPO sector. More than 20 transactions in the past three years have involved either PE firms or their portfolio companies.  This activity is forever changing the industry in pronounced ways. OEMs now encounter a new MPO landscape that has both great opportunities and challenges. The most visible impact of PE has been the injection of new capital into the industry. This capital has enabled the creation of larger platforms and firms with greater capabilities and resources. PE-backed firms have driven the opening of new facilities and the acquisition of complementary businesses. The result of this investment has been the creation of a number of new platforms providing OEMs with a broader range of outsourcing solutions.

    One of the earliest examples of PE involvement was the creation of MedSource Technologies Inc. MedSource was created in 1999 through the combination of seven smaller companies. In 2004, MedSource combined with another PE-backed firm, UTI, to create Accellent. The resulting large company offered a broad range of manufacturing services fully focused on the medical device market. Accellent’s creation demonstrated that size and breadth of capabilities matter to OEMs but that one still could not overlook successful integration and customer responsiveness.  While it can certainly be debated how successful this platform was from the customer’s perspective, it did provide a very healthy return for the initial investors and served as an example of what could be done in this market. This successful investment led others to actively pursue the MPO market. KRG Capital Partners, an investor in UTI, immediately followed up its investment by acquiring the MedTech Group Inc. and starting a second platform, which has since become Vention Medical. Building upon the lessons learned in creating UTI and MedSource, they and others have focused more on effectively integrating the various pieces.

    Companies such as Vention, Phillips-Medisize, AdvanceCath, and Creganna could not have scaled without the heavy financial resources and deal acumen that PE firms bring. These platforms successfully created new combinations of service offerings for OEMs that previously had not existed. While acquisitions still occurred prior to the entrance of PE, the range and number of transactions has increased markedly. Yet another benefit in creating these platforms is that PE firms have worked to professionalize the management of contract manufacturers and have attracted new managerial talent to the industry. This has effectively transformed MPO from a cottage industry into a more developed, cohesive global presence.

    While it is easy to think of all PE as the same, not all PE investments have followed the roll-up and exit formula in the MPO industry. There are PE firms that have employed internally-focused strategies to success. Schooner Capital is a firm that does not have money tied to a specific investment fund and as a consequence, has the flexibility to invest over a longer time horizon.  Schooner acquired Millstone Medical Outsourcing more than 10 years ago and still owns it today. Rather than pursuing a rapid acquisition strategy, Millstone has relied on organic growth and elected to invest internally, where it has successfully grown into a larger business with a unique offering.

    One of the benefits of PE investing has been a marked increase in liquidity options for business owners. With a healthy supply of capital, PE firms are willing buyers and provide a range of exit opportunities for owners that did not exist previously. This capital and activity has had an additional impact—rising valuations. Greater activity among a broader range of buyers has led to a steady rise in valuations for MPO companies.

    While PE firms have created new options for OEMs, it has not been without its challenges. One of the side effects of an acquisition strategy is that some customer relationships get strained in the transition—contacts change and responsiveness may suffer. There can be significant management turnover and business processes change (not always for the better).

    Companies become used to how a relationship works and PE involvement inevitably brings about change. Most OEMs can point to examples where one of their trusted suppliers was acquired and the net results were less than satisfactory. The argument that some PE-backed firms have been more focused on growth than customer service can certainly be made.

    The other challenge for OEMs is that PE has different priorities than more traditional owners.  PE’s objective is to rapidly increase the value of the business, which generally means focusing on profitability and scale (greater efficiency). The other factor driving PE behavior is timing.  Most PE firms need to invest and liquidate their funds within a set time period. This ensures that  investors receive their money within a reasonable period of time. While individual fund mandates differ, most funds look to maintain an investment for five years or so. But with an incentive to maximize profits over a short-term horizon, there is less incentive to invest in the business and maintain certain customer relationships. 

    This creates an interesting dilemma from the OEM perspective. OEMs today are looking for strategic outsourcing partners and are investing a great deal of time and resources into partners that will help them produce and manage a product globally. While PE-backed firms give them  large platforms with broad and innovative offerings, they do raise the question of how long these firms will be around. From the OEM perspective, one must enter into a relationship with a PE-backed MPO provider with a full understanding of what the provider’s motivations are and be cognizant that the owners they are working with today may not be the owners they will be working with two years from now. In addition, because relationships are changing, OEMs need to consider how important they are to the MPO provider and whether they will receive the level of service they require.

    For the owner of an MPO business that is not PE-backed, there are a number of things to consider. Putting aside the distracting calls and outreach they constantly receive, one needs to be cognizant that they are part of an incredibly dynamic environment and that the pace of change is greatly accelerating. PE has unleashed forces and money that is forever changing the MPO landscape. The competitors they face today will not be the same competitors they will face tomorrow. New platforms will form and older ones will disappear. As with any change, this presents companies with opportunities and threats—the bottom line is to be prepared for this change and understand how to react.

    PE has enabled the creation of new, innovative platforms in the MPO industry, providing a greater range of alternatives for OEMs. In addition, they have provided much-needed investment and liquidity alternatives into a vibrant industry. This growth has helped to drive the industry but has also strained some key industry relationships. As PE accelerates the pace of change and disrupts industry dynamics, the primary stakeholders—OEMs and MPO providers—need to take notice, keeping in mind the motivations of the groups they are dealing with and plan accordingly. 


    Ben Dunn is a managing director with Boston, Mass.-based Covington Associates. For more than 20 years, he has advised medical technology companies in the areas of mergers, acquisitions, investments, and strategic partnerships. Having advised clients on more than 100 transactions, Dunn has represented both private and public companies on both the buy and sell side. He is a frequent speaker at healthcare conferences and the author of numerous articles, including the white paper, “Medical Device Outsourcing Industry: Emerging Trends and Opportunities.”
    Related Searches
    • lifepak 1000 defibrillator
    • consumer
    • oem
    • medical product outsourcing
    Related Knowledge Center
    • Contract Manufacturing
    Suggested For You
    Millstone Medical Outsourcing Millstone Medical Outsourcing
    Medical Device Funding: Any Signs of Life? Medical Device Funding: Any Signs of Life?
    Sounding Board: The BD-Bard Transaction Sounding Board: The BD-Bard Transaction
    Winners Announced for Qualcomm Tricorder XPRIZE Winners Announced for Qualcomm Tricorder XPRIZE
    The Tax that Wouldn’t Die The Tax that Wouldn’t Die
    A Legal Eye’s View of Medtech M&A A Legal Eye’s View of Medtech M&A
    Collaborative R&D Collaborative R&D
    The Complex Science of Private Company Valuations The Complex Science of Private Company Valuations
    FDA 2015: A Look Back (and Ahead)—Part 1 FDA 2015: A Look Back (and Ahead)—Part 1
    Millstone Medical Adds Capacity to MS Operations Millstone Medical Adds Capacity to MS Operations
    Millstone Medical Outsourcing Expands Mississippi Facility Millstone Medical Outsourcing Expands Mississippi Facility
    Millstone Medical Completes Headquarters Expansion Millstone Medical Completes Headquarters Expansion
    Millstone Completes Headquarters Expansion Millstone Completes Headquarters Expansion
    Managing Reputation Risks for Medical Device Companies Managing Reputation Risks for Medical Device Companies
    Millstone Medical Outsourcing to Break Ground for Headquarters Expansion Millstone Medical Outsourcing to Break Ground for Headquarters Expansion

    Related Buyers Guide Companies

    • Millstone Medical Outsourcing

      Millstone Medical Outsourcing

      ...
      Brittany Arnone, Marketing Manager 11.11.22

    • Medical Device Funding: Any Signs of Life?

      Medical Device Funding: Any Signs of Life?

      ...
      Ben Dunn, Managing Director, Covington Associates 05.01.17

    • Sounding Board: The BD-Bard Transaction

      Sounding Board: The BD-Bard Transaction

      Members of the medtech industry share their opinions on the impact of the latest merger activity.
      Sean Fenske, Editor 04.24.17


    • Diagnostics | Digital Health | Electronics
      Winners Announced for Qualcomm Tricorder XPRIZE

      Winners Announced for Qualcomm Tricorder XPRIZE

      Final Frontier Medical Devices took home 1st place, receiving $2.6M for their artificial intelligence-based engine.
      XPRIZE Foundation

    • The Tax that Wouldn’t Die

      The Tax that Wouldn’t Die

      ...
      Sean Fenske, Editor 04.03.17

    Loading, Please Wait..

    Trending
    • Study: Smartphone Therapeutic Helps Improve Fibromyalgia In Patients
    • CGM Devices Could Become Main Glucose Monitoring Solution In U.S.
    • Environmental Sustainability Becoming Increasingly Important To Medtech Industry
    • The Future Of Biomedical Engineering Advancements
    • A New Approach To Post-Market Surveillance
    Breaking News
    • MO SCI Acquires Assets of 3M’s Advanced Materials Business
    • Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
    • Aspivix's Carevix Cervical Stabilizer Gains FDA OK
    • Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
    • LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy
    View Breaking News >
    CURRENT ISSUE

    January/February 2023

    • Struggling Suppliers in Electronics Manufacturing Services (EMS)
    • Machining & Laser Processing Have Huge Parts to Play
    • Medtech R&D Teams Must Be Creative & Resilient to Survive
    • Medtronic Neuromodulation President, Nnamdi Njoku, Interview
    • 6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Elects New Board Officers for 2023
    Aspire Hires Darrec Jones as VP of Business Development
    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    Coatings World

    Latest Breaking News From Coatings World

    PPG Completes COLORFUL COMMUNITIES Project in Denmark
    10 Partners of the Automotive Industry Form JV, Cofinity-X
    BASF Recognized as Top Company for Supplier Diversity
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MO SCI Acquires Assets of 3M’s Advanced Materials Business
    Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
    Aspivix's Carevix Cervical Stabilizer Gains FDA OK
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Lilly 4Q Revenues Down 9% to $7.3B
    Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity
    Steriline Provides Fill-Finish Solution for Berkshire Sterile Manufacturing
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Pacifica Introduces Glow Baby Skincare Line
    Kohl’s Names Tom Kingsbury as Chief Executive Officer
    Mielle Unveils Haircare Bundles Inspired by Amazon Original Series Harlem
    Happi

    Latest Breaking News From Happi

    Grant Industries Names Mehran Ghadim Sales Manager, Canada
    Bio-Oil Celebrates Body Confidence Through Body Positivity Month Campaign
    Net Sales for Clorox Increase 1% for Q2 2023
    Ink World

    Latest Breaking News From Ink World

    Roland DGA Announces Key Changes to Leadership Team
    Ball Reports 2022 Results
    3D Printing Materials Market Worth $7.9 Billion by 2027: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    MM Packaging adds first Nilpeter press for Dublin site
    Polytag develops new UV tag reading technology
    Enterprise Print Group adds Screen Truepress Jet L350UV SAI E
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    What You’re Reading on Nonwovens-Industry.com
    Kimberly-Clark Supports Period Poverty Initiative in Australia
    Suominen Reports Q4, Full Year Results
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Toetal Solutions Secures $1.8 Million in New Financing
    Adrian Tyndall Joins Axogen's Board of Directors
    ADSM-Synchro Medical Acquired by Tyber Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Zebra Provides East West Shrine Bowl with RFID Tracking Technology
    AAAS Elects Three ORNL Scientists as Fellows
    Flex Recognized as One of Fortune World’s Most Admired Companies 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login